<DOC>
	<DOCNO>NCT02055300</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability escalate single oral dos LY03005 healthy subject characterize pharmacokinetics ( PK ) escalate single oral dos LY03005 .</brief_summary>
	<brief_title>Safety , Tolerability Pharmacokinetics Study LY03005</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<criteria>1 . Are capable give informed consent comply study procedure ; 2 . Are age 18 45 year , inclusive ; 3 . Female subject negative pregnancy test result prior enrollment , meet follow criterion define : 1 . If childbearing potential , agree avoid pregnancy study one month end study use least one effective contraceptive method ( ) , intrauterine device ( IUD ) , diaphragm spermicide , oral contraceptive use least one month prior screening , injectable progesterone , progesterone subdermal implant . 2 . Surgically sterile least 3 month prior screen one follow mean : Bilateral tubal ligation Salpingectomy ( without oophorectomy ) Surgical hysterectomy Bilateral oophorectomy ( without hysterectomy ) 3 . Postmenopausal , define one following : Last menstrual period great 12 month prior screen 4 . Considered healthy Principal Investigator , base detailed medical history , full physical examination , clinical laboratory test , 12lead ECG vital sign ; 5 . Nonsmoker , define smoke used form tobacco 6 month screen ; 6 . Body mass index ( BMI ) 19 32 kg/m2 inclusive body weight less 50 kg ; 7 . Willing able adhere study restriction confine clinical research center . 1 . Clinically significant history gastrointestinal , cardiovascular , musculoskeletal , endocrine , hematologic , psychiatric , renal , hepatic , bronchopulmonary , neurologic , immunologic , lipid metabolism disorder , drug hypersensitivity ; 2 . Subjects mean systolic blood pressure three measurement &gt; 130 mmHG , mean diastolic blood pressure three measurement &gt; 90 mmHG screening . 3 . History presence malignancy adequately treat basal cell skin cancer 4 . Positive blood screen human immunodeficiency virus ( HIV ) , hepatitis B surface antigen ( HBsAg ) , hepatitis C antibody ; 5 . A history seizure . However , history febrile seizure allow ; 6 . Positive pregnancy test result , plan pregnant female ; 7 . A hospital admission major surgery within 30 day prior screen ; 8 . Participation investigational drug trial within 30 day last dosing trial screen ; 9 . A history prescription drug abuse , illicit drug use within 6 month prior screen ; 10 . A history alcohol abuse accord medical history within 6 month prior screen ; 11 . A positive screen alcohol , drug abuse ; 12 . Tobacco use within 6 month prior screen ; 13 . An unwillingness inability comply food beverage restriction study participation ; 14 . Donation blood collection 1 unit ( approximate 450 mL ) blood ( blood product ) acute loss blood 90 day prior screen ; 15 . Use prescription overthecounter ( OTC ) medication , herbal ( include St John 's Wort , herbal tea , garlic extract ) within 14 day prior dose ( Note : Use acetaminophen &lt; 3g/day permit 24 hour prior dose ) ; 16 . A history intolerance hypersensitivity venlafaxine desvenlafaxine excipients ; 17 . Patients history suicide attempt past 6 month and/or see investigator significant history risk suicide homicide ; 18 . An unwillingness male participant use appropriate contraceptive measure engage sex intercourse female partner childbearing potential . Appropriate measure include use condom spermicide , female partner , use intrauterine device ( IUD ) , diaphragm spermicide , oral contraceptive , injectable progesterone , progesterone subdermal implant , tubal ligation . Sexual intercourse pregnant lactate woman prohibit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>